Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
World Journal of Urology|August 1, 2024
Prospective close monitoring of the effect of vascular-targeted photodynamic therapy and high intensity focused ultrasound of localized prostate cancer by multiparametric magnetic resonance imagingOlga Solyanik, Michael Chaloupka, Dirk-André Clevert, et al.
Journal of Neuromuscular Diseases|June 27, 2022
Slowly Progressive Limb-Girdle Weakness and HyperCKemia - Limb Girdle Muscular Dystrophy or Anti-3-Hydroxy-3-Methylglutaryl-CoA-Reductase-Myopathy?Miriam Hiebeler, Raimo Franke, Maria Ingenerf, et al.
Radiology and Oncology|April 13, 2024
Utility of clinical and MR imaging parameters for prediction and monitoring of response to capecitabine and temozolomide (CAPTEM) therapy in patients with liver metastases of neuroendocrine tumorsMaria Ingenerf, Christoph Auernhammer, Roberto Lorbeer, et al.
Frontiers in Oncology|September 1, 2023
Evaluation of MRI in the diagnostic accuracy of extrahepatic metastases in neuroendocrine tumors in comparison with the reference standard somatostatin-receptor-PET/CTMaria Ingenerf, Johannes Rübenthaler, Vera Wenter, et al.
Diagnostics (Basel, Switzerland)|June 19, 2024
The Association between the Body Mass Index, Chronic Obstructive Pulmonary Disease and SUV of the Non-Tumorous Lung in the Pretreatment [<sup>18</sup>F]FDG-PET/CT of Patients with Lung CancerLukas Wehlte, Julia Walter, Lea Daisenberger, et al.
Diagnostic and Interventional Imaging|July 15, 2023
Neuroendocrine liver metastases treated using transarterial radioembolization: Identification of prognostic parameters at 68Ga-DOTATATE PET/CTMaria Ingenerf, Freba Grawe, Michael Winkelmann, et al.
European Journal of Radiology|April 2, 2023
Economic evaluation of 18F-FDG PET/CT, MRI and CE-CT in selection of colorectal liver metastases eligible for ablation - A cost-effectiveness analysisMoritz L Schnitzer, Janine Buchner, Gloria Biechele, et al.
Cancer Treatment and Research Communications|January 7, 2026
Impact of spleen volume and volume change in non-Hodgkin lymphoma treated with chimeric antigen receptor t-cell therapyChristina Quell, Wolfgang G Kunz, Viktoria Blumenberg, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|May 15, 2023
Staging of lymphoma under chimeric antigen receptor T-cell therapy: reasons for discordance among imaging response criteriaMichael Winkelmann, Viktoria Blumenberg, Kai Rejeski, et al.
Frontiers in Oncology|September 5, 2025
Elevated FDG uptake in non-tumorous lung regions does not predict immune checkpoint inhibitor-related pneumonitis in lung cancer patientsFriederike Völter, Lukas Wehlte, Blerina Resuli, et al.
Pageof 3